Oncology news
Sections: Cancer research | Cancer prevention | Czech oncology | NOP On-line project
Archive
Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women [1], led in the UK by Queen Mary University of London.
Colorectal cancer (CRC) incidence rates across Europe in adults aged 20 to 39 years increased by 6% every year between 2008 and 2016, new research has shown [1].
Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University School of Medicine in St. Louis [1].
In a study of postmenopausal women, participants who lost weight had a lower risk of developing invasive breast cancer than those who maintained or gained weight. Published early online in Cancer [1], a peer-reviewed journal of the American Cancer Society, the findings suggest that weight loss may help lower postmenopausal women’s breast cancer risk.
On 2 and 3 October 2018, the Masaryk Memorial Cancer Institute hosted a meeting of partners of the INTENT project, who arrived from four Central European countries: the Czech Republic, Hungary, Italy and Slovenia. The INTENT project aims to find solutions for innovative patient-centered cancer care.
Public awareness of urological conditions is alarmingly low throughout Europe. Results of a new international survey [1] of more than 2,500 responders from 5 countries show that women know more about men’s health issues than men do, men have poor knowledge of key urological symptoms and don’t take early signs of potentially life-threatening urological conditions seriously.
In 2018, an estimated 18.1 million new cases cancer will be diagnosed globally, and 9.6 million will die from the disease, according to the latest report from the International Agency for Research on Cancer (IARC) [1].
A new cutting-edge Special Issue from ecancermedicalscience [1] collects six original review articles that examine the complex relationship between microbes and cancer, from cause to treatment and beyond.
As in most developed European countries, a vaccination programme against HPV has also been introduced in the Czech Republic. HPV vaccines are reimbursed from the public health insurance if the first dose is administered between ages 13 and 14. Both girls and boys can be vaccinated under this scheme.
Yet another study has confirmed that the introduction of screening mammography is linked to a subsequent decline in breast cancer mortality. New findings have just been published in the Journal of Medical Screening [1].
New evidence published in the Cochrane Library [1] shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26. It also summarises findings on harms that have been assessed in randomised controlled trials.
A new study by the International Agency for Research on Cancer (IARC), published online in the Annals of Oncology [1], found that there was no association between circulating vitamin D levels and lung cancer risk. The report presents a robust analysis of more than 5300 case-control pairs nested within 20 international prospective cohort studies. This is the largest observational study to date on the relationship between vitamin D and cancer.
A new study [1] suggests that a diet free from red meat significantly reduces the risk of a type of colon cancer in women living in the United Kingdom.
Colorectal cancer is the third most common cancer in men and the second most common in women and represents almost 10% of the annual global cancer incidence. Yet the disease is preventable with a healthy lifestyle and efficient screening. The International Agency for Research on Cancer (IARC) Handbooks of Cancer Prevention programme has evaluated the effectiveness of various colorectal cancer screening methods.
A large international study has shown that an MRI scan can reduce the number of invasive prostate biopsies by up to 28%. The PRECISION [1] trial shows that using MRI to target prostate biopsies leads to more of the harmful prostate cancers, and fewer harmless cancers being diagnosed. Given that more than a million men in Europe undergo a prostate biopsy every year, the authors believe that this work could change clinical practice. The results are presented at the European Association of Urology Congress in Copenhagen, with simultaneous publication in The New England Journal of Medicine [2].
Inviting men with no symptoms to a one-off PSA test for prostate cancer does not save lives according to results from the largest ever prostate cancer trial conducted over 10 years by Cancer Research UK-funded scientists and published today (Tuesday) in the Journal of the American Medical Association (JAMA) [1].
If first-degree relatives are affected by colorectal cancer, this indicates a person’s own elevated risk of developing bowel cancer. The same holds true for people who have large numbers of genetic risk markers in their genome. Both factors are usually used alternatively, not combined, to predict risk. Scientists from the German Cancer Research Center (DKFZ) in Heidelberg have now shown that a combination of family history and an analysis of genetic markers helps determine a person’s colorectal cancer risk more precisely.
Improvement and innovation of cancer care and its availability to all citizens belongs to EU priorities in the area of public health. The INTENT project is one of the new contributions in this field, aiming to find solutions for innovative patient-centred cancer care.
Researchers have developed a blood test based on combined analysis of DNA and proteins that may allow earlier detection of eight common cancer types. The findings have just been published in the journal Science [1].
Three recent studies have added further weight to the link between periodontitis and overall cancer risk. The first [1] showed that severe periodontitis was associated with a 24 percent increased risk. The second [2] and third [3] investigated the role of bacteria causing periodontitis in the development of oral cancers and certain other cancers.